Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Teva Pharmaceutical Fine Chemicals S.R.L.”

11 pharma patents match "Teva Pharmaceutical Fine Chemicals S.R.L." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 11
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 11 pharmaceutical patents matching "Teva Pharmaceutical Fine Chemicals S.R.L." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

11 results for “Teva Pharmaceutical Fine Chemicals S.R.L.” · 30,257 patents in full index Clear search

  1. US 7569729

    Stable atomoxetine hydrochloride, a process for the preparation thereof, and an analytical control of its stability

    Teva Pharmaceutical Fine Chemicals S.R.L. · Granted Aug 4, 2009 · Expires Jul 30, 2029

    granted
  2. US 7507861

    Process for the preparation of atomoxetine hydrochloride

    Teva Pharmaceutical Fine Chemicals S.R.L. · Granted Mar 24, 2009 · Expires Mar 19, 2029

    granted
  3. US 7488758

    Levalbuterol hydrochloride polymorph B

    Teva Pharmaceutical Fine Chemicals S.R.L. · Granted Feb 10, 2009 · Expires Feb 5, 2029

    granted
  4. US 7482489

    Enantiomerically pure (R)-albuterol dibenzoyltartrate and protected analogs thereof

    Teva Pharmaceutical Fine Chemicals S.R.L. · Granted Jan 27, 2009 · Expires Jan 22, 2029

    granted
  5. US 7465831

    Levalbuterol hydrochloride Polymorph A

    Teva Pharmaceutical Fine Chemicals S.R.L. · Granted Dec 16, 2008 · Expires Dec 11, 2028

    granted
  6. US 7462743

    Polymorphs of memantine hydrochloride

    Teva Pharmaceutical Fine Chemicals S.R.L. · Granted Dec 9, 2008 · Expires Dec 4, 2028

    granted
  7. US 7439398

    Enantiomerically pure atomoxetine and tomoxetine mandelate

    Teva Pharmaceutical Fine Chemicals S.R.L. · Granted Oct 21, 2008 · Expires Oct 16, 2028

    granted
  8. US 7439399

    Processes for the preparation of atomoxetine hydrochloride

    Teva Pharmaceutical Fine Chemicals S.R.L. · Granted Oct 21, 2008 · Expires Oct 16, 2028

    granted
  9. US 7378553

    Isolated atomoxetine impurity, processes for the preparation of atomoxetine impurities and their use as reference standards

    Teva Pharmaceutical Fine Chemicals S.R.L. · Granted May 27, 2008 · Expires May 22, 2028

    granted
  10. US 7355078

    Processes for the preparation of tomoxetine

    Teva Pharmaceutical Fine Chemicals S.R.L. · Granted Apr 8, 2008 · Expires Apr 3, 2028

    granted
  11. US 7317127

    Process for the optical resolution and recycling of tomoxetine

    Teva Pharmaceutical Fine Chemicals S.R.L. · Granted Jan 8, 2008 · Expires Jan 3, 2028

    granted